PersonExecutiveOperator
Moriah Nachbaur
Moriah Katherine Nachbaur is the Chief Business Officer at Pheast Therapeutics, a clinical-stage immuno-oncology company in Redwood City, California, pioneering macrophage checkpoint inhibitors to teach the immune system to destroy cancer cells. Drawing on two decades of cross-functional biopharma experience - from lab benches at Genentech to executive boardrooms at Coherus BioSciences and her own consulting firm MKN Biotech - she brings a rare blend of scientific literacy, operational depth, and strategic vision to one of oncology's most promising new frontiers: the innate immune system's untapped power against solid tumors.
biotechcancer-immunotherapychief-business-officerinnate-immunitymacrophage-checkpointanti-cd24
